title: Oral anticoagulation after catheter ablation of atrial fibrillation: caught in the attribution trap?
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, Clinical and Integrated Cardiovascular Sciences, and SWBH NHS trust, Birmingham, UK Atrial Fibrillation Competence NETwork (AFNET), Münster, Germany Department of Cardiovascular Medicine, Hospital of the University of Münster, Münster, Germany p.kirchhof@bham.ac.uk.
authors.forename: Paulus
authors.initials: P
authors.lastname: Kirchhof
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, Clinical and Integrated Cardiovascular Sciences, and SWBH NHS trust, Birmingham, UK.
authors.forename: Yanish
authors.initials: Y
authors.lastname: Purmah
authors.affiliation: Southlake Regional Health Centre, Heart Rhythm Program, Newmarket, Ontario, Canada.
authors.forename: Atul
authors.initials: A
authors.lastname: Verma
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000601:surgery*; D017115:Catheter Ablation; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants